Pancreatic Cancer Research

ResearcherCase Comprehensive Cancer CenterActive in the last 2 years

Faith Nakazzi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4855-7302; OpenAlex author ID A5041835601. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

  1. Vitamin B3 derivatives support pancreatic cancer cell survival and chemotherapy resistance. Co-author DOI 10.1016/j.canlet.2026.218334↗
  2. IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-23-1895↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mehrdad Zarei · 2 shared papers, 2024–2026 · strength 0.48
  2. Jordan Michael Winter · 2 shared papers, 2024–2026 · strength 0.48
  3. Luke Daniel Rothermel · 1 shared paper, 2024 · strength 0.18
  4. Jonathan J. Hue · 1 shared paper, 2024 · strength 0.18
  5. Ali Vaziri Gohar · 1 shared paper, 2024 · strength 0.18
  6. Omid Hajihassani · 1 shared paper, 2024 · strength 0.18
  7. Akram S. Shalaby · 1 shared paper, 2024 · strength 0.18
  8. Jonathan Robert Brody · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.